About
Basic Data Updated:
27 days agoIncorporated in 1993, Pharma Synth Formulations Limited is a renowned pharmaceutical company that specializes in the manufacturing of medicines. Its wide range of products includes ointments, creams, liquids, Vitalyte, Speedex, pharmaceutical drops, capsules, tablets, syrups, and powders. These products are carefully formulated to cater to the diverse needs of patients. The company's registered office is located in Delhi, showcasing its strong presence in the industry. The business of manufacturing medicines is the core focus of Pharma Synth Formulations Limited. Its products are known for their high quality and effectiveness, making them a preferred choice among healthcare professionals and patients alike. The company's portfolio is constantly expanding, with new and innovative products being added regularly. At Pharma Synth Formulations Limited, every step of the manufacturing process is carried out with utmost precision and care. From sourcing the finest ingredients to ensuring strict quality control measures, the company leaves no stone unturned in delivering safe and reliable medicines to its customers. With a strong commitment to improving the health and well-being of individuals, Pharma Synth Formulations Limited continues to be a trusted name in the pharmaceutical industry. Its dedication to excellence and customer satisfaction has earned it a reputable position in the market.
Industry
Company Details
- Location
East Delhi, Delhi, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U74899DL1993PLC056231 |
| Company No. | 056231 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 26 Nov 1993 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Delhi |
Products or Services related to Pharma Synth Formulations Limited
Oral Care Products
Health Drinks
Aloe Vera Cosmetics
Financials of Pharma Synth Formulations Limited
Pharma Synth Formulations Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.06% increase. The company also saw a slight improvement in profitability, with a 3.06% increase in profit. The company's net worth Soared by an impressive increase of 10.66%.
Corporate Structure
Unlock access to Pharma Synth Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Pharma Synth Formulations Limited
Unlock and access historical data on people associated with Pharma Synth Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 20 Jan 2023 | ₹16.00 Cr | Open |
Sidbi Creation Date: 28 Mar 2022 | ₹2.00 Cr | Open |
Canara Bank Creation Date: 21 Sep 2007 | ₹0.46 M | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Synth Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Synth Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
31 years Recent activity within the organization
Annual General Meeting
Pharma Synth Formulations Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Pharma Synth Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
31 Mar 2023Charges
A charge with Sidbi amounted to Rs. 1,600.00 Lakh with Charge ID 100674524 was registered on 20 Jan 2023.
20 Jan 2023Charges
A charge with Sidbi amounted to Rs. 200.00 Lakh with Charge ID 100551116 was registered on 28 Mar 2022.
28 Mar 2022Charges
A charge registered on 29 Jun 2005 via Charge ID 90044801 with Small Industries Development was fully satisfied on 24 Apr 2018.
24 Apr 2018
Frequently asked questions
What is the Incorporation or founding date of Pharma Synth Formulations Limited?
